Location History:
- Teutschenthal, DE (2014)
- Halle/Saale, DE (2022)
Company Filing History:
Years Active: 2014-2022
Title: The Innovative Contributions of Manja Gloser in Cancer Research
Introduction
Manja Gloser, an accomplished inventor based in Halle/Saale, Germany, has made significant strides in the field of cancer research through her innovative patent contributions. With a total of two patents to her name, Gloser exemplifies the spirit of innovation and dedication in the medical sciences.
Latest Patents
Her latest patents include advancements in fusion proteins designed for medical applications. The first patent involves "Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancer." This invention relates to fusion proteins that consist of an extradomain B of fibronectin (ED-B) and an APS domain made up of amino acids such as alanine, proline, serine, and optionally aspartic acid. Moreover, these fusion proteins come equipped with a coupling site that includes at least one cysteine, allowing their use for diagnosing or treating cancer and cardiovascular diseases.
The second patent is titled "Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin." This invention discusses novel hetero-multimeric proteins derived from modified ubiquitin that can bind ED-B with high affinity. The fusion proteins created from these recombinant proteins are applicable in various medical treatments, showcasing Gloser's commitment to improving health outcomes.
Career Highlights
Throughout her career, Manja Gloser has worked with prominent companies in the biopharmaceutical sector, including Scil Proteins GmbH and Navigo Proteins GmbH. Her expertise in protein engineering and development has positioned her as a leading figure in her field, driving innovations that can potentially transform treatment methodologies.
Collaborations
In her journey, Gloser has collaborated with notable coworkers such as Erik Fiedler and Arnd Steuernagel. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and expertise, leading to enhanced research outcomes and further innovations.
Conclusion
Manja Gloser stands out as a pioneering inventor whose contributions to the field of cancer research have significant implications for diagnosis and treatment options. With her advanced research on fusion proteins and specific binding proteins, she continues to push the boundaries of medical science, making strides in the fight against cancer and other diseases.